| Title |
Mitochondria Targeted Viral Replication and Survival Strategies—Prospective on SARS-CoV-2
|
|---|---|
| Published in |
Frontiers in Pharmacology, August 2020
|
| DOI | 10.3389/fphar.2020.578599 |
| Pubmed ID | |
| Authors |
Priya Gatti, Hema Saranya Ilamathi, Kiran Todkar, Marc Germain |
X Demographics
The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 12% |
| France | 2 | 4% |
| Malaysia | 1 | 2% |
| Argentina | 1 | 2% |
| Australia | 1 | 2% |
| Russia | 1 | 2% |
| Germany | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 37 | 73% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 86% |
| Practitioners (doctors, other healthcare professionals) | 4 | 8% |
| Scientists | 2 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 136 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 13% |
| Student > Ph. D. Student | 14 | 10% |
| Other | 13 | 10% |
| Student > Master | 11 | 8% |
| Student > Bachelor | 8 | 6% |
| Other | 22 | 16% |
| Unknown | 50 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 29 | 21% |
| Medicine and Dentistry | 15 | 11% |
| Agricultural and Biological Sciences | 13 | 10% |
| Immunology and Microbiology | 9 | 7% |
| Neuroscience | 3 | 2% |
| Other | 14 | 10% |
| Unknown | 53 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2023.
All research outputs
#1,306,037
of 25,765,370 outputs
Outputs from Frontiers in Pharmacology
#493
of 20,003 outputs
Outputs of similar age
#35,986
of 426,370 outputs
Outputs of similar age from Frontiers in Pharmacology
#31
of 452 outputs
Altmetric has tracked 25,765,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,003 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,370 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 452 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.